ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Search by Abstract Number Results

  • Abstract Number: 0246 • ACR Convergence 2024

    Selectively Targeting TRBV11-2+ T Cells in Multisystem Inflammatory Syndrome in Children (MIS-C) Using Bispecific T Cell-Engaging Antibodies

    Elana Shaw, Stephanie Glavaris, Brian Mog, Alexander Pearlman, Sarah DiNapoli, Jin Liu, Kyle J. Kaeo, Kenneth W. Kinzler, Chetan Bettegowda, Shibin Zhou, Bert Vogelstein, Suman Paul and Maximilian F. Konig, The Johns Hopkins University School of Medicine, Baltimore, MD

    Background/Purpose: Multisystem Inflammatory Syndrome in Children (MIS-C) is a rare but potentially deadly immune complication after infection with SARS-CoV-2. In patients with MIS-C, a striking…
  • Abstract Number: 0246 • ACR Convergence 2023

    Safety & Efficacy of SEL-212 in Patients with Gout Refractory to Conventional Treatment: Primary Outcomes from Two Randomized, Double Blind, Placebo-Controlled, Multicenter Phase 3 Studies

    Herbert Baraf1, Alan Kivitz2, Sheri Rhodes3, Sheldon Leung4, Olu Folarin4, Tania Gonzalez-Rivera5, Joanna Sobierska5, Jacquie Christie5, Anand Patel6, Wesley DeHaan4, Rehan Azeem4 and Peter Traber7, 1The Center for Rheumatology and Bone Research, George Washington University, Rheumatology, Bethesda, MD, 2Altoona Center for Clinical Research, Duncansville, PA, 3Selecta Biosciences, Atlanta, GA, 4Selecta Biosciences, Inc., Watertown, MA, 5Swedish Orphan Biovitrum (Sobi), Stockholm, Sweden, 6Pioneer Research Solutions, Houston, TX, 7Selecta Biosciences, Gladwyne, PA

    Background/Purpose: In patients with refractory gout, the inability to maintain serum uric acid (sUA) levels < 6 mg/dL leads to severe clinical manifestations for which…
  • Abstract Number: 0246 • ACR Convergence 2022

    Comorbidity Clusters in Patients with Rheumatoid Arthritis Predict Survival Prognosis

    Cynthia Crowson1, Tina Gunderson2, John Davis2, Elena Myasoedova2, Vanessa Kronzer2, Caitrin Coffey2, Bradly Kimbrough3 and Elizabeth Atkinson2, 1Mayo Clinic, Eyota, MN, 2Mayo Clinic, Rochester, MN, 3Mayo Clinic Rochester, Rochester, MN

    Background/Purpose: Comorbidities are common in patients with rheumatoid arthritis (RA), but there is little information regarding the occurrence of distinct comorbidity patterns in patients with…
  • Abstract Number: 0246 • ACR Convergence 2021

    Macrophage Activating Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis Treated with Biological Drugs

    Betul Sozeri1, Kenan Barut2, Erdal Atalay3, Aysenur Pac Kisaarslan4, Semanur Ozdel5, Ozge Altug6, Ferhat Demir1, Balahan Makay7, Nuray Aktay Ayaz8, Ersen Acar9, Fatih Haslak2, Erdal Sag10, Mehmet YILDIZ2, Ummusen Kaya Akca10, Amra Adrovic2, Yelda Bilginer10, Hakan Poyrazoglu11, Erbil Unsal7, Ozgur Kasapcopur12 and Seza Ozen3, 1University of Health Sciences, Umraniye Tranining and Research Hospital Division of Pediatric Rheumatology, Istanbul, Turkey, 2Istanbul University-Cerrahpasa, Faculty of Medicine, Pediatric Rheumatology, İstanbul, Turkey, 3Hacettepe University Faculty of Medicine, Pediatric Romatology, Ankara, Turkey, 4Erciyes University Medical Faculty, Pediatric Rheumatology, Kayeri, Turkey, 5Ankara Dr.Sami Ulus Gynecology and Pediatrics Research and Training Hospital, Pediatric Rheumatology, Ankara, Turkey, 6Dr Behcet Uz Children's Hospital, Pediatric Rheumatology, Izmir, Turkey, 7Dokuz Eylul University Faculty of Medicine, Pediatric Rheumatology, Izmir, Turkey, 8Istanbul University, Faculty of Medicine, Pediatric Rheumatology, İstanbul, Turkey, 9Novartis, Istanbul, Turkey, 10Hacettepe University, Division of Pediatric Rheumatology, Department of Pediatrics, Faculty of Medicine, Ankara, Turkey, 11Erciyes University Faculty of Medicine, Pediatric Rheumatology, Kayseri, Turkey, 12Istanbul University-Cerrahpasa, Cerrahpasa Medical School, İstanbul, Turkey

    Background/Purpose: Systemic Juvenile Idiopathic Arthritis (SJIA) is the most acute and severe form of JIA. Despite the substantial evidence supporting the effectiveness of biologic drugs…
  • Abstract Number: 0246 • ACR Convergence 2020

    Extreme Fatigue in Patients with Systemic Lupus Erythematosus and Neuropsychiatric Symptoms

    Rory Monahan1, Rolf Fronczek1, Jeroen Eikenboom1, Huub Middelkoop1, Liesbeth Beaart-van de Voorde1, Gisela Terwindt1, Nic van der Wee1, Thomas Huizinga1, Margreet Kloppenburg1 and Margreet Steup-Beekman1, 1Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: Fatigue is commonly described in chronic illnesses, especially in auto-immune disorders such as systemic lupus erythematosus (SLE). We aim to study the prevalence of…
Search Again »

Didn't find what you were looking for? Try the Advanced Search »

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology